{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:35:11Z","timestamp":1790836511054,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007634","name":"Ida Montinin S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007634","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9liuksen S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007083","name":"Orionin Tutkimuss\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007083","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010133","name":"Aarne Koskelon S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010133","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1016\/j.atherosclerosis.2011.01.018","type":"journal-article","created":{"date-parts":[[2011,1,22]],"date-time":"2011-01-22T04:24:12Z","timestamp":1295670252000},"page":"35-43","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["(Pro)renin receptors and angiotensin converting enzyme 2\/angiotensin-(1-7)\/Mas receptor axis in human aortic valve stenosis"],"prefix":"10.1016","volume":"216","author":[{"given":"Tuomas","family":"Peltonen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juha","family":"N\u00e4p\u00e4nkangas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasi","family":"Ohtonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jani","family":"Aro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenni","family":"Peltonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ylermi","family":"Soini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatu","family":"Juvonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jari","family":"Satta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heikki","family":"Ruskoaho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panu","family":"Taskinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2011.01.018_bib0005","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1056\/NEJM199907153410302","article-title":"Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly","volume":"341","author":"Otto","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2011.01.018_bib0010","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/MOL.0b013e3282a66099","article-title":"Aortic valve stenosis: an active atheroinflammatory process","volume":"18","author":"Helske","year":"2007","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.atherosclerosis.2011.01.018_bib0015","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1136\/hrt.2007.134783","article-title":"Aotic valve calcification: basic science to clinical practice","volume":"95","author":"Akat","year":"2009","journal-title":"Heart"},{"key":"10.1016\/j.atherosclerosis.2011.01.018_bib0020","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1152\/physrev.00036.2005","article-title":"Physiology of local renin\u2013angiotensin systems","volume":"86","author":"Paul","year":"2006","journal-title":"Physiol Rev"},{"key":"10.1016\/j.atherosclerosis.2011.01.018_bib0025","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1146\/annurev.pharmtox.010909.105610","article-title":"Tissue renin\u2013angiotensin\u2013aldosterone systems: targets for pharmacological therapy","volume":"50","author":"Bader","year":"2010","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.atherosclerosis.2011.01.018_bib0030","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1161\/01.CIR.0000035655.45453.D2","article-title":"Association of angiotensin-converting enzyme with low-density lipoprotein in aortic valvular lesions and in human plasma","volume":"106","author":"O\u2019Brien","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2011.01.018_bib0035","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1016\/j.jacc.2004.07.054","article-title":"Induction of local angiotensin II-producing systems in stenotic aortic valves","volume":"44","author":"Helske","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2011.01.018_bib0040","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1093\/eurheartj\/ehi706","article-title":"Possible role for mast cell-derived cathepsin G in the adverse remodelling of stenotic aortic valves","volume":"27","author":"Helske","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.atherosclerosis.2011.01.018_bib0045","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1161\/01.RES.87.5.e1","article-title":"A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1\u20139","volume":"87","author":"Donoghue","year":"2000","journal-title":"Circ Res"},{"key":"10.1016\/j.atherosclerosis.2011.01.018_bib0050","doi-asserted-by":"crossref","first-page":"8258","DOI":"10.1073\/pnas.1432869100","article-title":"Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas","volume":"100","author":"Santos","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.atherosclerosis.2011.01.018_bib0055","doi-asserted-by":"crossref","first-page":"H2281","DOI":"10.1152\/ajpheart.00618.2005","article-title":"Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1-7) in regulation of cardiovascular function","volume":"289","author":"Ferrario","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.atherosclerosis.2011.01.018_bib0060","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1161\/HYPERTENSIONAHA.109.145839","article-title":"New physiological concepts of the renin\u2013angiotensin system from the investigation of precursors and products of angiotensin I metabolism","volume":"55","author":"Ferrario","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.atherosclerosis.2011.01.018_bib0065","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1172\/JCI0214276","article-title":"Pivotal role of the renin\/prorenin receptor in angiotensin II production and cellular responses to renin","volume":"109","author":"Nguyen","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2011.01.018_bib0070","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1113\/expphysiol.2007.040030","article-title":"Prorenin and (pro)renin receptor: a review of available data from in vitro studies and experimental models in rodents","volume":"93","author":"Nguyen","year":"2008","journal-title":"Exp Physiol"},{"key":"10.1016\/j.atherosclerosis.2011.01.018_bib0075","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/hr.2009.206","article-title":"Signal transduction of the (pro)renin receptor as a novel therapeutic target for preventing end-organ damage","volume":"33","author":"Funke-Kaiser","year":"2010","journal-title":"Hypertens Res"},{"key":"10.1016\/j.atherosclerosis.2011.01.018_bib0080","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1681\/ASN.2009030300","article-title":"The biology of the (pro)renin receptor","volume":"21","author":"Nguyen","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.atherosclerosis.2011.01.018_bib0085","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1161\/CIRCULATIONAHA.106.685743","article-title":"Distinct downregulation of C-type natriuretic peptide system in human aortic valve stenosis","volume":"116","author":"Peltonen","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2011.01.018_bib0090","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1191\/0962280202sm289ra","article-title":"Analysis of data with excess zeros","volume":"11","author":"Lachenbruch","year":"2002","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.atherosclerosis.2011.01.018_bib0095","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.2353\/ajpath.2008.080457","article-title":"(Pro)renin receptor promotes choroidal neovascularization by activating its signal transduction and tissue renin\u2013angiotensin system","volume":"173","author":"Satofuka","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1016\/j.atherosclerosis.2011.01.018_bib0100","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.bbrc.2009.10.121","article-title":"Prorenin induces ERK activation in endothelial cells to enhance neovascularization independently of the renin\u2013angiotensin system","volume":"390","author":"Uraoka","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.atherosclerosis.2011.01.018_bib0105","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1093\/eurheartj\/ehm129","article-title":"Increased expression of profibrotic neutral endopeptidase and bradykinin type 1 receptors in stenotic aortic valves","volume":"28","author":"Helske","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.atherosclerosis.2011.01.018_bib0110","doi-asserted-by":"crossref","first-page":"R994","DOI":"10.1152\/ajpregu.2001.280.4.R994","article-title":"Mechanisms of angiotensin-(1-7)-induced inhibition of angiogenesis","volume":"280","author":"Machado","year":"2001","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.atherosclerosis.2011.01.018_bib0115","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1161\/HYPERTENSIONAHA.106.084848","article-title":"Angiotensin-(1-7) counterregulates angiotensin II signaling in human endothelial cells","volume":"50","author":"Sampaio","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.atherosclerosis.2011.01.018_bib0120","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1161\/01.CIR.0000160867.23556.7D","article-title":"G-protein-coupled receptor Mas is a physiological antagonist of the angiotensin II type 1 receptor","volume":"111","author":"Kostenis","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2011.01.018_bib0125","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1113\/expphysiol.2007.040345","article-title":"Genetically altered animal models for Mas and angiotensin-(1-7)","volume":"93","author":"Alenina","year":"2008","journal-title":"Exp Physiol"},{"key":"10.1016\/j.atherosclerosis.2011.01.018_bib0130","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1161\/01.HYP.0000251865.35728.2f","article-title":"Angiotensin-(1-7) through receptor Mas mediates endothelial nitric oxide synthase activation via Akt-dependent pathways","volume":"49","author":"Sampaio","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.atherosclerosis.2011.01.018_bib0135","doi-asserted-by":"crossref","first-page":"H2373","DOI":"10.1152\/ajpheart.00426.2008","article-title":"Regulation of ACE2 in cardiac myocytes and fibroblasts","volume":"295","author":"Gallagher","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.atherosclerosis.2011.01.018_bib0140","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/eurheartj\/ehn482","article-title":"Increase in tissue endothelin-1 and ETA-receptor levels in human aortic valve stenosis","volume":"30","author":"Peltonen","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.atherosclerosis.2011.01.018_bib0145","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1161\/01.CIR.0000017435.87463.72","article-title":"Atorvastatin inhibits hypercholesterolemia-induced cellular proliferation and bone matrix production in the rabbit aortic valve","volume":"105","author":"Rajamannan","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2011.01.018_bib0150","doi-asserted-by":"crossref","first-page":"I229","DOI":"10.1161\/01.CIRCULATIONAHA.104.524306","article-title":"Atorvastatin inhibits hypercholesterolemia-induced calcification in the aortic valves via Lrp5 receptor pathway","volume":"112","author":"Rajamannan","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2011.01.018_bib0155","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1080\/07853890802331394","article-title":"Prevention of calcific aortic valve stenosis \u2013 fact or fiction?","volume":"41","author":"Cawley","year":"2009","journal-title":"Ann Med"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915011000785?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915011000785?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T16:20:27Z","timestamp":1762186827000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915011000785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S0021915011000785"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2011.01.018","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"(Pro)renin receptors and angiotensin converting enzyme 2\/angiotensin-(1-7)\/Mas receptor axis in human aortic valve stenosis","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2011.01.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}